Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
891.55
17.90
(2.05%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences gains on getting USFDA’s approval for ‘Dapagliflozin Tablets’
>>
Zydus Lifesciences gets USFDA’s approval for ‘Dapagliflozin Tablets’
>>
Zydus Lifesciences launches Semaglutide Injection
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences enters into licensing and supply agreement with Torrent Pharmaceuticals
>>
Zydus Lifesciences, Lupin sign licensing agreement to co-market Semaglutide Injection in India
<<
<
1
2
3
...168
>
>>